Related Experiment Videos
GABAergic mechanisms in antinociception
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|January 1, 1984
Summary
GABAergic mechanisms modulate pain relief. Peripheral GABAergic agents enhance morphine
Area of Science:
- Neuroscience
- Pharmacology
Background:
- GABAergic mechanisms are implicated in pain modulation.
- Peripheral GABAergic agents can enhance morphine's antinociceptive effects, while central administration may inhibit them.
- GABAergic agents possess direct antinociceptive properties.
Purpose of the Study:
- To elucidate the roles of GABAA and GABAB receptors in antinociception.
- To investigate the complex interactions of GABAergic agents with opioid and other neurotransmitter systems in pain control.
Main Methods:
- Administration of GABAergic agents (agonists and antagonists) at central and peripheral sites.
- Assessment of antinociceptive effects and interactions with other drugs like morphine and bicuculline.
- Investigation of supraspinal and spinal mechanisms involving noradrenergic pathways and substance P.
Main Results:
- GABAA agonists (muscimol, THIP) produce antinociception supraspinally.
- GABAB agonist (baclofen) acts supraspinally and spinally, involving complex neurotransmitter pathways.
- D-baclofen acts as a spinal GABAB antagonist; GABA-transaminase inhibitors' effects are largely independent of bicuculline or baclofen manipulations.
Conclusions:
- GABAergic systems, particularly GABAA and GABAB receptors, play significant roles in antinociception.
- Further research is needed to clarify bicuculline's actions and utilize specific GABAB antagonists for a comprehensive understanding.